Read more

March 18, 2021
1 min read
Save

Use of evidence-based guidelines for lumbar fusion improved patient outcomes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients who met evidence-based medicine guidelines for elective lumbar fusion had a greater than three times improvement in outcomes compared with patients who did not meet evidence-based medicine guideline criteria, according to results.

Perspective from Wellington K. Hsu, MD

James S. Harrop, MD, and colleagues prospectively evaluated all elective lumbar fusion cases from March 2018 to August 2019 and categorized each based on whether they were deemed concordant with evidence-based medicine guidelines. Researchers collected baseline Oswestry Disability Index (ODI) and clinical variables and defined the minimum clinically significant difference as a reduction of five or more points in the ODI.

Of the 325 patients who underwent lumbar fusion, 95% had 6-month follow-up data available. Results showed a mean preoperative ODI of 24.4, with a median 6-month improvement of seven points. Researchers found ODI improved among 79.6% of patients, stayed the same in 3.8% of patients and worsened in 16% of patients. Researchers also noted 191 patients had ODI improvement reaching minimal clinically important difference (MCID), with 93.2% cases concordant with and 6.7% not concordant with evidence-based medicine guidelines.

James S. Harrop
James S. Harrop

Multivariate analysis results showed a significant association between improved functional outcome with evidence-based medicine concordance, lower preoperative ODI, lower American Society of Anesthesiologists score and primary surgeries. After adjusting for other factors, investigators found patients who met evidence-based medicine guidelines had a 3.04 times greater odds of achieving MCID in ODI at 6 months.

“Patients obtained the best clinical results if the surgeons followed evidence-based guidelines. This has more of an impact on successful outcome over who the surgeon was and what operative procedure was performed,” Harrop told Healio Orthopedics. “[The results] reinforce and highlight the need for high-level evidence-based clinical studies and the need for significant investment by stakeholders, including insurance companies, to support clinical trials.”